SUVENPHAR — Suven Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹208.90bn
- IN₹201.31bn
- IN₹10.51bn
Annual cashflow statement for Suven Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4,045 | 4,677 | 6,676 | 5,597 | 4,057 |
| Depreciation | |||||
| Non-Cash Items | 289 | 52.6 | 23.8 | -90 | -365 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -412 | -1,216 | -3,782 | -1,400 | -625 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,160 | 3,825 | 3,300 | 4,572 | 3,585 |
| Capital Expenditures | -994 | -1,108 | -752 | -2,859 | -518 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3,221 | -2,006 | -610 | 909 | -3,105 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,215 | -3,114 | -1,362 | -1,950 | -3,623 |
| Financing Cash Flow Items | -203 | -86.7 | -61.4 | -116 | -74.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 63.7 | -757 | -1,564 | -2,420 | -138 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.92 | -45.1 | 374 | 202 | -176 |